Downfalls of the FDA Accelerated Approval Pathway – Stringent Controls Must be Invoked to Ensure Prompt Submission of Follow-Up Confirmatory Trial Data
Macaulay, R.Volume:
17
Langue:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.03.569
Date:
May, 2014
Fichier:
PDF, 59 KB
english, 2014